The apparent discount to Big Food peers is difficult to interpret as a value opportunity because trailing P/E, TTM EV/EBITDA, and PEG are all unavailable or negative, suggesting the market is pricing a depressed and possibly non-recurring earnings base rather than a discounted cash-generating franchise. The 10.4% dividend yield, materially above Campbell Soup's 7.7% and General Mills' 7.5%, warrants investigation as to whether it is sustainable relative to the -4.9% free cash flow margin recorded in 2027Q1, given that quarterly dividends of roughly $167M continued even in negative-FCF quarters. A forward P/E below 8x may simply be the market discounting continued organic contraction of -3% to -1% guided for FY2027, rather than pricing a genuine recovery optionality.

The steady 450 basis point gross margin erosion suggests pricing power has weakened rather than input costs simply normalizing, which is consistent with the sustained revenue contraction across all ten reported quarters and management's guidance implying no volume recovery in fiscal 2027. Operating margin has oscillated between -19.1% and 15.5% while net income has swung from +$466.8M to -$663.6M, indicating that reported net margin is being driven substantially by impairments and restructuring rather than underlying operating performance. On this evidence, normalized operating margin and gross margin — not headline net margin — appear to be the metrics that best reflect Conagra's true earning power, and both are trending unfavorably versus the 10% to 13.5% range maintained through fiscal 2025.

ROIC is being constrained by both ends of the equation: an asset base that has contracted 26.5% to $16.1B — halved in effectiveness by goodwill still representing roughly 50% of total assets — alongside operating margins that have failed to hold above the mid-teens. ROE of 2.4% in 2027Q1, following readings of -7.8% and -6.4% in prior quarters, indicates no evidence of compounding; rather, returns appear to decay in step with each goodwill write-down, which mechanically shrinks the equity denominator without improving earning power. Investors should note that asset turnover of 0.15x is roughly a third of typical packaged-food peer levels implied by similar capital intensity, suggesting Conagra's returns are more asset-heavy than its frozen-aisle moat narrative would justify.

The headline deleveraging appears to have been funded substantially by goodwill write-downs — $3.0B written off over the period — rather than by retained earnings, since retained earnings simultaneously eroded $2.7B to $4.3B. D/EBITDA of 2.07 in 2027Q1 is low on the surface, yet the ratio reached 22.32 in 2025Q3 and remains around 17x on several trailing readings when EBITDA is depressed by charges, suggesting leverage metrics remain highly sensitive to how one normalizes the earnings denominator. Coverage of 3.25x in the latest quarter appears adequate against the reduced debt load, but the presence of prior negative-coverage quarters indicates that covenant or refinancing stress would re-emerge quickly if margin compression persists.

The structurally high DIO — consistently in the 85-to-98-day range across the series — is consistent with cold-chain inventory requirements but has not improved even as revenue contracted, suggesting the company is carrying inventory against demand that has not materialized. Working capital swings between -$320.8M and +$294.4M have been the dominant driver of cash flow volatility, with the -$255.2M drag in 2027Q1 converting $174.3M of net income into -$4.2M of operating cash flow, which indicates cash conversion is not reliable on a quarter-to-quarter basis. DSO of 25 days remains healthy and suggests retailer payment discipline is not a concern; the inefficiency is concentrated on the inventory and asset-utilization side rather than in receivables management.